Login / Signup

An Immune-Related Prognostic Signature for Predicting Clinical Outcomes and Immune Landscape in IDH-Mutant Lower-Grade Gliomas.

Gang XiaoXuan GaoLifeng LiChao LiuZhiyuan LiuHaiqin PengXuefeng XiaXin YiRongrong Zhou
Published in: Journal of oncology (2021)
-mutant gliomas, classifying patients into two subtypes with distinct immunophenotypes and overall survival.
Keyphrases
  • high grade
  • end stage renal disease
  • newly diagnosed
  • wild type
  • ejection fraction
  • chronic kidney disease
  • low grade
  • single cell
  • patient reported outcomes
  • drug induced